These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28617443)

  • 1. Bilirubin neurotoxicity is associated with proteasome inhibition.
    Huang H; Guo M; Liu N; Zhao C; Chen H; Wang X; Liao S; Zhou P; Liao Y; Chen X; Lan X; Chen J; Xu D; Li X; Shi X; Yu L; Nie Y; Wang X; Zhang CE; Liu J
    Cell Death Dis; 2017 Jun; 8(6):e2877. PubMed ID: 28617443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cadmium pyrithione suppresses tumor growth in vitro and in vivo through inhibition of proteasomal deubiquitinase.
    Chen X; Wu J; Yang Q; Zhang X; Zhang P; Liao S; He Z; Wang X; Zhao C; Liu J
    Biometals; 2018 Feb; 31(1):29-43. PubMed ID: 29098502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy.
    Zhao C; Chen X; Zang D; Lan X; Liao S; Yang C; Zhang P; Wu J; Li X; Liu N; Liao Y; Huang H; Shi X; Jiang L; Liu X; He Z; Dou QP; Wang X; Liu J
    Oncogene; 2016 Nov; 35(45):5916-5927. PubMed ID: 27086925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hinokitiol copper complex inhibits proteasomal deubiquitination and induces paraptosis-like cell death in human cancer cells.
    Chen X; Zhang X; Chen J; Yang Q; Yang L; Xu D; Zhang P; Wang X; Liu J
    Eur J Pharmacol; 2017 Nov; 815():147-155. PubMed ID: 28887042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells.
    Chitta K; Paulus A; Akhtar S; Blake MK; Caulfield TR; Novak AJ; Ansell SM; Advani P; Ailawadhi S; Sher T; Linder S; Chanan-Khan A
    Br J Haematol; 2015 May; 169(3):377-90. PubMed ID: 25691154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of 19S proteasome associated deubiquitinases in activity-dependent hippocampal synaptic plasticity.
    Yun D; Zhuang Y; Kreutz MR; Behnisch T
    Neuropharmacology; 2018 May; 133():354-365. PubMed ID: 29407217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Proteasomal Deubiquitinase by Silver Complex Induces Apoptosis in Non-Small Cell Lung Cancer Cells.
    Chen X; Yang Q; Chen J; Zhang P; Huang Q; Zhang X; Yang L; Xu D; Zhao C; Wang X; Liu J
    Cell Physiol Biochem; 2018; 49(2):780-797. PubMed ID: 30165348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases.
    Liu N; Liu C; Li X; Liao S; Song W; Yang C; Zhao C; Huang H; Guan L; Zhang P; Liu S; Hua X; Chen X; Zhou P; Lan X; Yi S; Wang S; Wang X; Dou QP; Liu J
    Sci Rep; 2014 Jun; 4():5240. PubMed ID: 24912524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Chymotrypsin-Like Activity of the Proteasome during Ischemia Induces Myocardial Dysfunction and Death.
    Sanchez G; Berrios D; Olmedo I; Pezoa J; Riquelme JA; Montecinos L; Pedrozo Z; Donoso P
    PLoS One; 2016; 11(8):e0161068. PubMed ID: 27529620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxic mechanisms by which the USP14 inhibitor IU1 depletes ubiquitinated proteins and Tau in rat cerebral cortical neurons: Relevance to Alzheimer's disease.
    Kiprowska MJ; Stepanova A; Todaro DR; Galkin A; Haas A; Wilson SM; Figueiredo-Pereira ME
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1157-1170. PubMed ID: 28372990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetogenic agent alloxan is a proteasome inhibitor.
    Zhou W; Wei L; Xiao T; Lai C; Peng M; Xu L; Luo X; Deng S; Zhang F
    Biochem Biophys Res Commun; 2017 Jun; 488(2):400-406. PubMed ID: 28502636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase.
    Yue X; Zuo Y; Ke H; Luo J; Lou L; Qin W; Wang Y; Liu Z; Chen D; Sun H; Zheng W; Zhu C; Wang R; Wen G; Du J; Zhou B; Bu X
    Biochem Pharmacol; 2017 Aug; 137():29-50. PubMed ID: 28476333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro analysis of proteasome-associated USP14 activity for substrate degradation and deubiquitylation.
    Muniyappan S; Lee BH
    Methods Enzymol; 2019; 619():249-268. PubMed ID: 30910023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms.
    Lan X; Zhao C; Chen X; Zhang P; Zang D; Wu J; Chen J; Long H; Yang L; Huang H; Carter BZ; Wang X; Shi X; Liu J
    J Hematol Oncol; 2016 Nov; 9(1):129. PubMed ID: 27884201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulforaphane attenuates postnatal proteasome inhibition and improves spatial learning in adult mice.
    Sunkaria A; Bhardwaj S; Yadav A; Halder A; Sandhir R
    J Nutr Biochem; 2018 Jan; 51():69-79. PubMed ID: 29096318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases.
    Zhao C; Chen X; Yang C; Zang D; Lan X; Liao S; Zhang P; Wu J; Li X; Liu N; Liao Y; Huang H; Shi X; Jiang L; Liu X; Dou QP; Wang X; Liu J
    Oncotarget; 2017 Feb; 8(8):13942-13956. PubMed ID: 28086217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactive USP14 and inactive UCHL5 cause accumulation of distinct ubiquitinated proteins in mammalian cells.
    Chadchankar J; Korboukh V; Conway LC; Wobst HJ; Walker CA; Doig P; Jacobsen SJ; Brandon NJ; Moss SJ; Wang Q
    PLoS One; 2019; 14(11):e0225145. PubMed ID: 31703099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ubiquitin-proteasome pathway as a target for therapeutic strategies].
    Staszczak M
    Postepy Biochem; 2017; 63(4):287-303. PubMed ID: 29374430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasome deubiquitinases as novel targets for cancer therapy.
    D'Arcy P; Linder S
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1729-38. PubMed ID: 22819849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational and biochemical studies of isothiocyanates as inhibitors of proteasomal cysteine deubiquitinases in human cancer cells.
    Ahmed ZSO; Li X; Li F; Cheaito HA; Patel K; Mosallam EM; Elbargeesy GAEH; Dou QP
    J Cell Biochem; 2018 Nov; 119(11):9006-9016. PubMed ID: 30015387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.